ID

24291

Beschrijving

Study ID: 100468 Clinical Study ID: AVA100468 Study Title: An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia XR,Avandia; Avandia XR,Rosiglitazone XR,Avandia Study Indication: Alzheimer's Disease Study Conclusion

Trefwoorden

Versies (1)
  1. 28-07-17 28-07-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

28 juli 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC-ND 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

  • Nieuwste
  • Oudste
  • Populair
  • Nieuwste
    • Nieuwste
    • Oudste
    • Populair

Geen commentaren

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Study Conclusion GSK Rosiglitazone Alzheimer's disease 100468

Engels

Study Conclusion GSK Rosiglitazone Alzheimer's disease 100468

1 Formulieren  
Patient Information
Beschrijving

Patient Information

Alias
UMLS CUI-1
C1955348
Subject Identifier
Beschrijving

Subject Identifier

Datatype

text

Alias
UMLS CUI [1]
C2348585
Pregnancy Information
Beschrijving

Pregnancy Information

Alias
UMLS CUI-1
C0032961
Did the subject become pregnant during the study?
Beschrijving

If Yes, complete Pregnancy Notification form.

Datatype

text

Alias
UMLS CUI [1]
C0032961
Study Conclusion
Beschrijving

Study Conclusion

Alias
UMLS CUI-1
C1707478
Date of subject completion or withdrawal
Beschrijving

Completion, Withdrawal

Datatype

date

Maateenheden
  • dd-mmm-yy
Alias
UMLS CUI [1]
C0805732
UMLS CUI [2]
C2349954
dd-mmm-yy
Was the subject withdrawn from the study?
Beschrijving

* If YES, specify the primary reason.

Datatype

text

Alias
UMLS CUI [1]
C2349954
If Yes, tick the primary reason for withdrawal:
Beschrijving

Primary Reason of Withdrawal

Datatype

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1549995
If Yes, tick the primary reason for withdrawal: If Other, specify:
Beschrijving

Primary Reason of Withdrawal Specification

Datatype

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1549995
UMLS CUI [1,3]
C2348235
Investigator's Signature
Beschrijving

Investigator's Signature

Alias
UMLS CUI-1
C2346576
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below. Investigator's name (print)
Beschrijving

Investigature's name

Datatype

text

Alias
UMLS CUI [1]
C2346576
Date of Report
Beschrijving

Date of Report

Datatype

date

Maateenheden
  • dd-mmm-yy
Alias
UMLS CUI [1]
C1302584
dd-mmm-yy
Terug naar het begin van de pagina

Similar models

Study Conclusion GSK Rosiglitazone Alzheimer's disease 100468

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
Item
Did the subject become pregnant during the study?
text
C0032961 (UMLS CUI [1])
Pregnancy
Code List
Did the subject become pregnant during the study?
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Not Applicable (not of childbearing potential or male) (X)
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
Completion, Withdrawal
Item
Date of subject completion or withdrawal
date
C0805732 (UMLS CUI [1])
C2349954 (UMLS CUI [2])
Item
Was the subject withdrawn from the study?
text
C2349954 (UMLS CUI [1])
Withdrawn
Code List
Was the subject withdrawn from the study?
CL Item
Yes* (Y)
CL Item
No (N)
Item
If Yes, tick the primary reason for withdrawal:
text
C2349954 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
Primary Reason of Withdrawal
Code List
If Yes, tick the primary reason for withdrawal:
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropirate) (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Other (Z)
Primary Reason of Withdrawal Specification
Item
If Yes, tick the primary reason for withdrawal: If Other, specify:
text
C2349954 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Item Group
Investigator's Signature
C2346576 (UMLS CUI-1)
Investigature's name
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below. Investigator's name (print)
text
C2346576 (UMLS CUI [1])
Date of Report
Item
Date of Report
date
C1302584 (UMLS CUI [1])
Terug naar het begin van de pagina 

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial